<DOC>
	<DOC>NCT03048604</DOC>
	<brief_summary>The study is designed as a prospective, open-label, multicentre, non-randomized, single arm treatment study to assess the safety, performance and initial efficacy trends of the GenioTM System in patients with Obstructive Sleep Apnoea (OSA).</brief_summary>
	<brief_title>BiLAteral Hypoglossal Nerve Stimulation for Treatment of Obstructive Sleep Apnoea (BLAST OSA)</brief_title>
	<detailed_description />
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea, Obstructive</mesh_term>
	<criteria>Main Body mass index â‰¤32 kg/m2 Patients who do not tolerate or do not accept positive airway pressure (PAP) treatments. Obstructive apnoeahypopnea index (AHI) of 2060 events/hour Main Unable or incapable of providing informed written consent Unwilling or incapable of returning to all followup visits and sleep studies, including evaluation procedures and filling out questionnaires Significant comorbidities making the patient unable or inappropriate to participate in the trial</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>